世界の肺炎市場インサイト及び予測(~2026年)

【英語タイトル】Global Pneumonia Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV04303)・商品コード:QYR20NV04303
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:93
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは肺炎の世界市場について調査・分析した資料です。種類別(薬、ワクチン、酸素療法)の市場規模、用途別(病院、外来外科センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別肺炎の競争状況、市場シェア
・世界の肺炎市場:種類別市場規模 2015年-2020年(薬、ワクチン、酸素療法)
・世界の肺炎市場:種類別市場規模予測 2021年-2026年(薬、ワクチン、酸素療法)
・世界の肺炎市場:用途別市場規模 2015年-2020年(病院、外来外科センター、その他)
・世界の肺炎市場:用途別市場規模予測 2021年-2026年(病院、外来外科センター、その他)
・北米の肺炎市場分析:米国、カナダ
・ヨーロッパの肺炎市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肺炎市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肺炎市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肺炎市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、GlaxoSmithKline(GSK)、Merck、Novartis、Sanofi、Eli Lilly
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.

Market Analysis and Insights: Global Pneumonia Market
The global Pneumonia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Pneumonia Scope and Market Size
Pneumonia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly

Market segment by Type, the product can be split into
Drugs
Vaccines
Oxygen Therapy
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumonia Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Vaccines
1.4.4 Oxygen Therapy
1.5 Market by Application
1.5.1 Global Pneumonia Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pneumonia Market Perspective (2015-2026)
2.2 Global Pneumonia Growth Trends by Regions
2.2.1 Pneumonia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pneumonia Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumonia Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Players by Market Size
3.1.1 Global Top Pneumonia Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumonia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumonia Market Concentration Ratio
3.2.1 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumonia Revenue in 2019
3.3 Pneumonia Key Players Head office and Area Served
3.4 Key Players Pneumonia Product Solution and Service
3.5 Date of Enter into Pneumonia Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Market Size by Application (2015-2020)
5.2 Global Pneumonia Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pneumonia Market Size (2015-2020)
6.2 Pneumonia Key Players in North America (2019-2020)
6.3 North America Pneumonia Market Size by Type (2015-2020)
6.4 North America Pneumonia Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pneumonia Market Size (2015-2020)
7.2 Pneumonia Key Players in Europe (2019-2020)
7.3 Europe Pneumonia Market Size by Type (2015-2020)
7.4 Europe Pneumonia Market Size by Application (2015-2020)

8 China
8.1 China Pneumonia Market Size (2015-2020)
8.2 Pneumonia Key Players in China (2019-2020)
8.3 China Pneumonia Market Size by Type (2015-2020)
8.4 China Pneumonia Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pneumonia Market Size (2015-2020)
9.2 Pneumonia Key Players in Japan (2019-2020)
9.3 Japan Pneumonia Market Size by Type (2015-2020)
9.4 Japan Pneumonia Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pneumonia Market Size (2015-2020)
10.2 Pneumonia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumonia Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumonia Market Size by Application (2015-2020)

11 India
11.1 India Pneumonia Market Size (2015-2020)
11.2 Pneumonia Key Players in India (2019-2020)
11.3 India Pneumonia Market Size by Type (2015-2020)
11.4 India Pneumonia Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pneumonia Market Size (2015-2020)
12.2 Pneumonia Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumonia Market Size by Type (2015-2020)
12.4 Central & South America Pneumonia Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Pneumonia Introduction
13.1.4 Pfizer Revenue in Pneumonia Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline(GSK)
13.2.1 GlaxoSmithKline(GSK) Company Details
13.2.2 GlaxoSmithKline(GSK) Business Overview
13.2.3 GlaxoSmithKline(GSK) Pneumonia Introduction
13.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2015-2020)
13.2.5 GlaxoSmithKline(GSK) Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Pneumonia Introduction
13.3.4 Merck Revenue in Pneumonia Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Pneumonia Introduction
13.4.4 Novartis Revenue in Pneumonia Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Pneumonia Introduction
13.5.4 Sanofi Revenue in Pneumonia Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Pneumonia Introduction
13.6.4 Eli Lilly Revenue in Pneumonia Business (2015-2020)
13.6.5 Eli Lilly Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pneumonia Key Market Segments
Table 2. Key Players Covered: Ranking by Pneumonia Revenue
Table 3. Ranking of Global Top Pneumonia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pneumonia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Vaccines
Table 7. Key Players of Oxygen Therapy
Table 8. Global Pneumonia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pneumonia Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pneumonia Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pneumonia Market Share by Regions (2015-2020)
Table 12. Global Pneumonia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pneumonia Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pneumonia Market Growth Strategy
Table 18. Main Points Interviewed from Key Pneumonia Players
Table 19. Global Pneumonia Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pneumonia Market Share by Players (2015-2020)
Table 21. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia as of 2019)
Table 22. Global Pneumonia by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pneumonia Product Solution and Service
Table 25. Date of Enter into Pneumonia Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pneumonia Market Size Share by Type (2015-2020)
Table 29. Global Pneumonia Revenue Market Share by Type (2021-2026)
Table 30. Global Pneumonia Market Size Share by Application (2015-2020)
Table 31. Global Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pneumonia Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pneumonia Market Share (2019-2020)
Table 35. North America Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pneumonia Market Share by Type (2015-2020)
Table 37. North America Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pneumonia Market Share by Application (2015-2020)
Table 39. Europe Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pneumonia Market Share (2019-2020)
Table 41. Europe Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pneumonia Market Share by Type (2015-2020)
Table 43. Europe Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pneumonia Market Share by Application (2015-2020)
Table 45. China Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pneumonia Market Share (2019-2020)
Table 47. China Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 48. China Pneumonia Market Share by Type (2015-2020)
Table 49. China Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 50. China Pneumonia Market Share by Application (2015-2020)
Table 51. Japan Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pneumonia Market Share (2019-2020)
Table 53. Japan Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pneumonia Market Share by Type (2015-2020)
Table 55. Japan Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pneumonia Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pneumonia Market Share (2019-2020)
Table 59. Southeast Asia Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pneumonia Market Share by Type (2015-2020)
Table 61. Southeast Asia Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pneumonia Market Share by Application (2015-2020)
Table 63. India Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pneumonia Market Share (2019-2020)
Table 65. India Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 66. India Pneumonia Market Share by Type (2015-2020)
Table 67. India Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 68. India Pneumonia Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pneumonia Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pneumonia Market Share (2019-2020)
Table 71. Central & South America Pneumonia Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pneumonia Market Share by Type (2015-2020)
Table 73. Central & South America Pneumonia Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pneumonia Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. GlaxoSmithKline(GSK) Company Details
Table 81. GlaxoSmithKline(GSK) Business Overview
Table 82. GlaxoSmithKline(GSK) Product
Table 83. GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline(GSK) Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Sanofi Company Details
Table 96. Sanofi Business Overview
Table 97. Sanofi Product
Table 98. Sanofi Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 99. Sanofi Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Product
Table 103. Eli Lilly Revenue in Pneumonia Business (2015-2020) (Million US$)
Table 104. Eli Lilly Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Oxygen Therapy Features
Figure 5. Global Pneumonia Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Pneumonia Report Years Considered
Figure 10. Global Pneumonia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pneumonia Market Share by Regions: 2020 VS 2026
Figure 12. Global Pneumonia Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pneumonia Market Share by Players in 2019
Figure 15. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pneumonia Revenue in 2019
Figure 17. North America Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Pneumonia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed


【掲載企業】

Pfizer、GlaxoSmithKline(GSK)、Merck、Novartis、Sanofi、Eli Lilly

★調査レポート[世界の肺炎市場インサイト及び予測(~2026年)] (コード:QYR20NV04303)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肺炎市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆